Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

trastuzumab

Known as: Anti-p185-HER2, Anti-HER2/c-erbB2 Monoclonal Antibody, Anti-c-ERB-2 
A monoclonal antibody that binds to HER2 (human epidermal growth factor receptor 2), and can kill HER2-positive cancer cells. Monoclonal antibodies… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND There is no recommended therapy for malignant pleural mesothelioma that has progressed after first-line pemetrexed and… Expand
Is this relevant?
Review
2019
Review
2019
During tumor progression, a subset of cancer cells escape from immune surveillance and eventually develop into measurable tumor… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Review
2019
Review
2019
PURPOSE Nivolumab, an anti-programmed death-1 monoclonal antibody, has demonstrated frequent and durable responses in relapsed… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2019
Review
2019
Targeted delivery of therapeutic molecules into cancer cells is considered as a promising strategy to tackle cancer. Antibody… Expand
Is this relevant?
Review
2018
Review
2018
OBJECTIVE We conducted a phase I trial of neoadjuvant nivolumab, a monoclonal antibody to the programmed cell death protein 1… Expand
Is this relevant?
Review
2018
Review
2018
Anti-programmed cell death-1 (anti-PD1) antibodies are currently the first-line treatment for patients with metastatic BRAF wild… Expand
Is this relevant?
Review
2018
Review
2018
Subcutaneous delivery of biotherapeutics has become a valuable alternative to intravenous administration across many disease… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2018
Review
2018
Since the identification of the HER2 receptor amplification as an adverse prognostic factor that defined a special subtype of… Expand
  • table 1
Is this relevant?
Review
2018
Review
2018
BACKGROUND The present review is part of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study… Expand
  • figure 2
  • table 1
  • table 2
Is this relevant?
Review
2018
Review
2018
BACKGROUND Cancer is one of the leading causes of death worldwide. Over the years, a number of conventional cytotoxic approaches… Expand
Is this relevant?